Bioactivation Screening

Bioactivation Screening is a systematic methodological framework used in drug discovery and toxicology research to identify compounds that undergo metabolic transformation into reactive metabolites, thereby distinguishing potential bioactivation pathways that may lead to toxicity from those that do not.

47

Publications

2.3K

Citations

267

Authors

79

Institutions

Publications per year

2017–2026

11

Authors

267

  1. SJ
    S. Joshua Swamidass

    Washington University in St. Louis, United States

    3 publications · 60 citations

    3

    h-index

  2. AS
    Amit S. Kalgutkar

    Pfizer (United States), United States

    3 publications · 308 citations

    3

    h-index

  3. GS
    Gregory S. Walker

    Pfizer (United States), United States

    2 publications · 95 citations

    2

    h-index

  4. DA
    Dustyn A. Barnette

    University of Arkansas for Medical Sciences, United States

    2 publications · 40 citations

    2

    h-index

  5. ML
    Márcio Luís Andrade e Silva

    Universidade de Franca, Brazil

    2 publications · 69 citations

    2

    h-index

1–5 of 267

Venues

  1. Chemical Research in Toxicology

    8 publications · 544 citations

    8

    h-index

  2. Mutagenesis

    4 publications · 99 citations

    4

    h-index

  3. Toxicological Sciences

    3 publications · 149 citations

    2

    h-index

  4. PubMed

    Repository · 2 publications · 118 citations

    2

    h-index

  5. Journal of Medicinal Chemistry

    2 publications · 57 citations

    2

    h-index

1–5